(Q33377211)

26 July 2017

title

Bimonthly 24 h infusion of high-dose 5-fluorouracil vs EAP regimen in patients with advanced gastric cancer. A randomized phase II study (English)

1 reference

26 July 2017

1 reference

I P Popov

1

1 reference

26 July 2017

S B Jelić

2

1 reference

26 July 2017

Z V Krivokapić

3

1 reference

26 July 2017

S D Jezdić

4

1 reference

26 July 2017

P M Pesko

5

1 reference

26 July 2017

M T Micev

6

1 reference

26 July 2017

D R Babić

7

1 reference

26 July 2017

publication date

1 November 2007

1 reference

26 July 2017

1 reference

26 July 2017

volume

25

1 reference

26 July 2017

issue

1

1 reference

26 July 2017

page(s)

73-80

1 reference

https://scigraph.springernature.com/pub.10.1007/s12032-007-0042-8

26 July 2017

exact match

0 references

cites work

Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer

1 reference

12 December 2020

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

12 December 2020

FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer

1 reference

12 December 2020

Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracil

1 reference

12 December 2020

Combined-modality therapy for gastric cancer

1 reference

12 December 2020

The treatment of advanced gastric cancer

1 reference

12 December 2020

Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO).

1 reference

12 December 2020

Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer

1 reference

12 December 2020

Advances in the therapy of gastric cancer

1 reference

12 December 2020

Chemotherapy in gastric cancer: a review and updated meta-analysis

1 reference

12 December 2020

Cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) is more active than 5-fluorouracil, doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma

1 reference

12 December 2020

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

1 reference

12 December 2020

High-dose 5-fluorouracil / folinic acid in combination with three-weekly mitomycin C in the treatment of advanced gastric cancer. A phase II study

1 reference

12 December 2020

Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial

1 reference

12 December 2020

Chemotherapy of metastatic gastric cancer.

1 reference

12 December 2020

Gastric cancer: epidemiology, pathology and treatment.

1 reference

12 December 2020

Eight-hour infusion versus bolus injection of doxorubicin in the EAP regimen in patients with advanced gastric cancer: a prospective randomised trial

1 reference

12 December 2020

Chemotherapy for advanced gastric cancer: where do we stand?

1 reference

12 December 2020

Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer

1 reference

12 December 2020

10.1007/S12032-007-0042-8

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

1044038591

0 references

Fatcat ID

release_pf7lah766rebppzs55kjebxsiu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pf7lah766rebppzs55kjebxsiu

24 November 2022

mapped directly with Wikidata item

1 reference